🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the potential of high doses of rif...
Status
Completed
Location
University of Florida
Start Date
2013-09
Trial ID
NCT01408914
Treatments Being Tested
Tuberculosis (TB) is a leading cause of death in HIV-infected individuals. ...
Status
Unknown
Location
Infectious Diseases Institute
Start Date
2013-02
Trial ID
NCT01782950
Treatments Being Tested
AlpE is a novel drug combination under development for the treatment of TB,...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-30
Trial ID
NCT07350174
Treatments Being Tested
In countries with a high tuberculosis (TB) prevalence, TB and invasive bact...
Status
Completed
Location
Sihanouk Hospital Center of Hope
Start Date
2014-09
Trial ID
NCT02057796
To determine if a high-dose first-line regimen is non-inferior (non-inferio...
Status
Recruiting
Location
Damien Foundation
Start Date
2021-03-01
Trial ID
NCT04260477
RIFAstrat is a Phase 3, double-blind, placebo-controlled, non-inferiority t...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-02-01
Trial ID
NCT07118696
Treatments Being Tested
In this trial, the investigators are assessing whether giving an increased ...
Status
Completed
Location
University of Botswana
Start Date
2017-02-01
Trial ID
NCT02581527
Treatments Being Tested
This trial aims to determine whether the early bactericidal activity of rif...
Status
Completed
Location
De La Salle Health Institute
Start Date
2019-02-11
Trial ID
NCT02381470
Treatments Being Tested
REMoxTB is a study for the "Rapid Evaluation of Moxifloxacin in the treatme...
Status
Completed
Location
Beijing Tuberculosis and Thoracic Tumor Research Institute
Start Date
2008-01
Trial ID
NCT00864383
Treatments Being Tested
The purpose of this study is to assess the efficacy, safety and tolerabilit...
Status
Completed
Location
National Center for Tuberculosis and Lung Diseases
Start Date
2015-02
Trial ID
NCT02342886